impact factor, citescore
logo
 

One year in review

 

One year in review 2020: Behçet’s syndrome


1, 2, 3, 4, 5

 

  1. Division of Rheumatology, Department of Internal Medicine and Behçet’s Disease Research Centre, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  2. Division of Rheumatology, Department of Internal Medicine and Behçet’s Disease Research Centre, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  3. Division of Rheumatology, Department of Internal Medicine and Behçet’s Disease Research Centre, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  5. Division of Rheumatology, Department of Internal Medicine and Behçet’s Disease Research Centre, Istanbul University-Cerrahpasa, School of Medicine, Istanbul, Turkey. vhamuryudan@yahoo.com

CER14139
2020 Vol.38, N°5 ,Suppl.127
PI 0003, PF 0010
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 33331271 [PubMed]

Received: 22/10/2020
Accepted : 30/11/2020
In Press: 10/12/2020
Published: 10/12/2020

Abstract

Behçet’s syndrome is a variable vessel vasculitis with multi-system involvement that shows important heterogeneity among patients regarding demographic features, organ manifestations, frequency and severity of relapses, disease course, response to treatment and prognosis. This heterogeneity has made it difficult to interpret and compare the results of studies, to standardise disease assessment and to develop management strategies. Several new studies have been published during the previous year exploring the epidemiology, pathogenesis, clinical manifestations, diagnosis, and management of Behçet’s syndrome. The aim of this review is to provide an overview of the most relevant recent research in Behçet’s syndrome from a critical perspective.

Rheumatology Article